References
- Coats L, Tsang V, Khambadkone S, van Doorn C, et al. The potential impact of percutaneous pulmonary valve stent implantation on right ventricular outflow tract re-intervention. Eur J Cardiothorac Surg 2005;27:536-543
- Frigiola A, Nordmeyer J, Bonhoeffer P. Percutaneous pulmonary valve replacement. Coron Artery Dis 2009;20:189-191
- Homann M, Haehnel JC, Mendler N, et al. Reconstruction of the RVOT with valved biological conduits: 25 years’ experience with allografts and xenografts. Eur J Cardiothorac Surg 2000;17:624-630
- Khambadkone S, Coats L, Taylor A, et al. Percutaneous pulmonary valve implantation in humans results in 59 consecutive patients. Circulation 2005;112:189-197
- Nordmeyer J, Coats L, Taylor AM, et al. Benefits of percutaneous pulmonary valve implantation are sustained after 1 year. Circulation 2006;114(Suppl S):390
- Nordmeyer J, Coats L, Lurz P, et al. Percutaneous pulmonary valve-in-valve implantation: a successful treatment concept for early device failure. Eur Heart J 2008;20:810-815
- Lurz P, Coats L, Khambadkone S, et al. Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome. Circulation 2008;117:1964-1972
- Rosengart T, Feldman T, Borger M, et al. Percutaneous and minimally invasive valve procedures. A scientific statement from the American Heart Association Council on cardiovascular surgery and anesthesia, Council on Clinical Cardiology, Functional Genomics and Translational Biology Interdisciplinary Working Group, and Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2008;117:1750-1767